Choose a language
0 reviews
Talus Bio is a biotechnology company specializing in the discovery and development of therapeutics targeting previously undruggable transcription factors—proteins that regulate gene expression and are implicated in various diseases, including cancer, diabetes, and neurological conditions. Founded in 2020 and based in Seattle, Talus Bio integrates advanced proteomics, synthetic chemistry, artificial intelligence, and computational biology to engineer and analyze drugs, proteins, and genomics at an unprecedented scale.